Cargando…

Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors

Currently, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has infected people among all countries and is a pandemic as declared by the World Health Organization (WHO). SARS-CoVID-2 main protease is one of the therapeutic drug targets that has been shown to reduce virus replication, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalhotra, Poonam, Chittepu, Veera C. S. R., Osorio-Revilla, Guillermo, Gallardo-Velazquez, Tzayhri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916619/ https://www.ncbi.nlm.nih.gov/pubmed/33578831 http://dx.doi.org/10.3390/molecules26040936

Ejemplares similares

Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study
por: Chittepu, Veera C. S. R., et al.
Publicado: (2019)

Structure–Activity Relationship and Molecular Docking of Natural Product Library Reveal Chrysin as a Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: An Integrated In Silico and In Vitro Study
por: Kalhotra, Poonam, et al.
Publicado: (2018)

Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes
por: Kalhotra, Poonam, et al.
Publicado: (2019)

Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus
por: Kalhotra, Poonam, et al.
Publicado: (2020)

Designed Functional Dispersion for Insulin Protection from Pepsin Degradation and Skeletal Muscle Cell Proliferation: In Silico and In Vitro Study
por: Chittepu, Veera C. S. R., et al.
Publicado: (2018)

New Molecular Insights into the Inhibition of Dipeptidyl Peptidase-4 by Natural Cyclic Peptide Oxytocin
por: Chittepu, Veera C. S. R., et al.
Publicado: (2019)

A Cavity Corrected 3D-RISM Functional for Accurate Solvation Free Energies
por: Truchon, Jean-François, et al.
Publicado: (2014)

To Pass or Not To Pass: Predicting the Blood–Brain Barrier Permeability with the 3D-RISM-KH Molecular Solvation Theory
por: Roy, Dipankar, et al.
Publicado: (2019)

Microencapsulation of Rambutan Peel Extract by Spray Drying
por: Boyano-Orozco, Luis, et al.
Publicado: (2020)

Identification and Quantification of Adulterants in Coffee (Coffea arabica L.) Using FT-MIR Spectroscopy Coupled with Chemometrics
por: Flores-Valdez, Mauricio, et al.
Publicado: (2020)

Structural Fluctuation, Relaxation, and Folding of Protein: An Approach Based on the Combined Generalized Langevin and RISM/3D-RISM Theories
por: Hirata, Fumio
Publicado: (2023)

Understanding the Liquid States of Cyclic Hydrocarbons Containing N, O, and S Atoms via the 3D-RISM-KH Molecular Solvation Theory
por: Roy, Dipankar, et al.
Publicado: (2022)

Uses of FT-MIR Spectroscopy and Multivariate Analysis in Quality Control of Coffee, Cocoa, and Commercially Important Spices
por: Castillejos-Mijangos, Lucero Azusena, et al.
Publicado: (2022)

Molecular Recognition and Self-Organization in Life Phenomena Studied by a Statistical Mechanics of Molecular Liquids, the RISM/3D-RISM Theory
por: Sugita, Masatake, et al.
Publicado: (2021)

3D-RISM-AI: A Machine Learning Approach to Predict Protein–Ligand Binding Affinity Using 3D-RISM
por: Osaki, Kazu, et al.
Publicado: (2022)

Non-continuum solvation using the EC-RISM method applied to predict tautomer ratios, pK(a) and enantiomeric excess of alkylation reactions
por: Heil, Jochen, et al.
Publicado: (2012)

Identification of Variety and Prediction of Chemical Composition in Cocoa Beans (Theobroma cacao L.) by FT-MIR Spectroscopy and Chemometrics
por: Castillejos-Mijangos, Lucero Azusena, et al.
Publicado: (2023)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease
por: OKTAY, Lalehan, et al.
Publicado: (2021)

Competitive interaction of monovalent cations with DNA from 3D-RISM
por: Giambaşu, George M., et al.
Publicado: (2015)

SAMPL7 physical property prediction from EC-RISM theory
por: Tielker, Nicolas, et al.
Publicado: (2021)

Comprehensive ensemble in QSAR prediction for drug discovery
por: Kwon, Sunyoung, et al.
Publicado: (2019)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Extraction and Microencapsulation of Bioactive Compounds from Muicle (Justicia spicigera) and Their Use in the Formulation of Functional Foods
por: Castro-Alatorre, Norma Cristina, et al.
Publicado: (2021)

An ensemble model of QSAR tools for regulatory risk assessment
por: Pradeep, Prachi, et al.
Publicado: (2016)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

FDA-Approved Natural Polymers for Fast Dissolving Tablets
por: Alam, Md Tausif, et al.
Publicado: (2014)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tspmegtdjc8h0a4thle2ij4jc5